Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Abroad (travel likely)RecruitingPHASE1

Conditions

T-cell Acute Lymphoblastic Lymphoma · T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Rayne Rouce, MD

    Principal Investigator

    Baylor College of Medicine